Hairy Cell Leukemia: A Review of Epidemiology and Disease Presentation
Despite the significant progress that has been made regarding the incidence, risk factors, and symptoms of hairy cell leukemia, diagnosis remains a challenge, due in part to the low incidence of the disease.
A Rare but Treatable Disease: Therapeutic Considerations for Hairy Cell Leukemia
Martin S. Tallman, MD, discusses the biology, presentation, and available therapeutic options in hairy cell leukemia.
Hairy Cell Leukemia Pathogenesis, Diagnosis, and Prognosis
The pathogenesis, diagnostic criteria, staging, and prognosis of hairy cell leukemia, an uncommon indolent B-cell lymphoid neoplasm, is examined.
Continued ADC Development in NSCLC Necessitates Improved Knowledge of Mechanisms and Biomarker Optimization
Neoadjuvant vs Perioperative Immune Checkpoint Blockade in Resectable NSCLC: How Do We Choose?
EGFR TKI–Based Combinations May Revolutionize Frontline EGFR+ NSCLC Management
Dr Olazagasti on a Case-Based Discussion of ALK-Mutated NSCLC Treatment
2 Commerce Drive Cranbury, NJ 08512